﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xsi:schemaLocation="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2017v2.3">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2019-02-13T16:02:01-06:00</ReturnTs>
    <TaxPeriodEndDt>2018-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>BDO USA LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>9500 Bryn Mawr Ave Suite 300</AddressLine1Txt>
        <CityNm>Rosemont</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60018</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>841558631</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Pulmonary Fibrosis Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% SCOTT STASZAK COO</InCareOfNm>
      <BusinessNameControlTxt>PULM</BusinessNameControlTxt>
      <PhoneNum>3122652182</PhoneNum>
      <USAddress>
        <AddressLine1Txt>230 East Ohio Street Suite 500</AddressLine1Txt>
        <CityNm>Chicago</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>606113270</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>SCOTT STASZAK</PersonNm>
      <PersonTitleTxt>COO</PersonTitleTxt>
      <PhoneNum>3125879272</PhoneNum>
      <SignatureDt>2018-12-06</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>Jacob Cook</PreparerPersonNm>
      <PTIN>P01240455</PTIN>
      <PhoneNum>8476762000</PhoneNum>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>73.74.16.103</IPv4AddressTxt>
      </IPAddress>
      <FederalOriginalSubmissionId>15782020190445000005</FederalOriginalSubmissionId>
      <FederalOriginalSubmissionIdDt>2019-02-13</FederalOriginalSubmissionIdDt>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>342C69388EA7BCA13281E38B3DD773C2383BC7B2</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>342C69388EA7BCA13281E38B3DD773C2383BC7B2</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2017</TaxYr>
    <BuildTS>2019-02-21 02:37:17Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO">
      <PrincipalOfficerNm>SCOTT STASZAK</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>230 E Ohio Street Suite 500</AddressLine1Txt>
        <CityNm>Chicago</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>606113270</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>13482516</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.pulmonaryfibrosis.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2000</FormationYr>
      <LegalDomicileStateCd>CO</LegalDomicileStateCd>
      <ActivityOrMissionDesc>to mobilize people and resources to provide access to high-quality care and lead research for a cure so that people with pulmonary fibrosis will live longer, healthier lives.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>10</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>10</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>39</TotalEmployeeCnt>
      <TotalVolunteersCnt>1138</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>14037</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>5775504</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>5989047</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>2841566</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>2993145</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>11355</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>82559</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>-143511</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>-321285</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>8484914</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>8743466</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>387250</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>208811</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>2813826</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>3149318</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>1245873</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>3956095</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>4986086</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>7157171</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>8344215</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>1327743</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>399251</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>10614119</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>8884514</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>4899554</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>2777874</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>5714565</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>6106640</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>TO MOBILIZE PEOPLE AND RESOURCES TO PROVIDE ACCESS TO HIGH-QUALITY CARE AND LEAD RESEARCH FOR A CURE SO THAT PEOPLE WITH PULMONARY FIBROSIS WILL LIVE LONGER, HEALTHIER LIVES.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>2313961</ExpenseAmt>
      <RevenueAmt>2489985</RevenueAmt>
      <Desc>PFF Patient Registry: Total revenue recognized for the program was $2,685,985, which included contributions and sponsorships of $196,000 in addition to the program service revenue of $2,489,985. The PFF Patient Registry (Registry) is a research-focused collaborative effort that will bring together multiple stakeholders including patients, health care providers, and researchers to advance research and improve the quality of life of patients with pulmonary fibrosis. (Continued on Schedule O)</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>752955</ExpenseAmt>
        <RevenueAmt>275228</RevenueAmt>
        <Desc>PFF Summit: Total revenue recognized for the PFF Summit was $1,177,643, which included $902,415 in contributions and sponsorships received during the year or released from prior year receipts as well as program service revenue of $275,228. PFF Summit 2017 is the PFF's biennial international health care conference on Pulmonary Fibrosis (PF). (Continued on Schedule O) caregivers that address their growing educational needs. (Note: Some expenses for the PFF Summit 2017 were included in the 2016 Form 990).</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>629722</ExpenseAmt>
        <Desc>Education: Total unrestricted revenue recognized in the year for our educational programs totaled $576,169, comprised of contributions and sponsorships. The Pulmonary Fibrosis Foundation (PFF) is committed to providing quality disease education to the pulmonary fibrosis community. The PFF strives to provide patients, caregivers, family members, and health care providers with the resources necessary to more fully understand PF, and to provide patients with the tools necessary to live with the disease and improve their quality of life. (Continued on Schedule O)</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalOtherProgSrvcExpenseAmt>2424581</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcRevenueAmt>229096</TotalOtherProgSrvcRevenueAmt>
      <TotalProgramServiceExpensesAmt>6121219</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="IRS990ScheduleC">false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="IRS990ScheduleC">true</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="IRS990ScheduleC">false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="IRS990ScheduleD">false</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="IRS990ScheduleM">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="IRS990ScheduleM">false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>45</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>39</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>true</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>true</Form990TFiledInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>10</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>10</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>DC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OK</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>SCOTT STASZAK COO</PersonNm>
        <PhoneNum>3122652182</PhoneNum>
        <USAddress>
          <AddressLine1Txt>230 EAST OHIO STREET SUITE 500</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>George Eliades PhD</PersonNm>
        <TitleTxt>Chairman</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Colleen Atwell</PersonNm>
        <TitleTxt>Vice-Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>David McNinch</PersonNm>
        <TitleTxt>Vice-Chair</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Dave Steffy</PersonNm>
        <TitleTxt>Treasurer thru 11/09/2017</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Laurie Chandler CFP</PersonNm>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Terence Hales</PersonNm>
        <TitleTxt>Secretary</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Dan Rose MD</PersonNm>
        <TitleTxt>Dir/Sr Advisr thru 11/09/2017</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Mike Henderson</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kathleen Lindell</PersonNm>
        <TitleTxt>Director thru 12/31/2017</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Nick Devito</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Jeff Harris</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Wendy Mason</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Stephen Wald</PersonNm>
        <TitleTxt>Director thru 01/26/2018</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Naftali Kaminski MD</PersonNm>
        <TitleTxt>Director thru 04/01/2018</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>William Schmidt</PersonNm>
        <TitleTxt>President/CEO as of 08/14/2017</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>128808</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>2063</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Scott Staszak</PersonNm>
        <TitleTxt>Chief Operating Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>266462</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>7994</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Laura Sadler</PersonNm>
        <TitleTxt>Chief Program &amp; Bus Dev Offcr</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>170961</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>13480</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Rex Edwards</PersonNm>
        <TitleTxt>VP, CCN &amp; PFF Patient Registry</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>133478</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>9251</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kerrie Trebonsky</PersonNm>
        <TitleTxt>VP, Finance</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>117332</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14121</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Zoe Bubany</PersonNm>
        <TitleTxt>VP, Board &amp; External Relations</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>104539</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>8139</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Jeri Webb</PersonNm>
        <TitleTxt>Associate VP, Conf &amp; Meetings</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>106511</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>3221</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Heather Kundert</PersonNm>
        <TitleTxt>SR DR, Corp Rel thru 06/4/2018</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>100058</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>8233</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1128149</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>66502</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>8</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>Dorothy Coyle Raclaw</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>5855 N Kenneth Ave</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60646</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>Marketing Consulting</ServicesDesc>
        <CompensationAmt>129438</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>791110</FundraisingAmt>
      <AllOtherContributionsAmt>5197937</AllOtherContributionsAmt>
      <NoncashContributionsAmt>112113</NoncashContributionsAmt>
      <TotalContributionsAmt>5989047</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PFF PATIENT REGISTRY</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>2489985</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2489985</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>OTHER PROGRAM SERVICE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>503160</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>503160</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>2993145</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>69969</TotalRevenueColumnAmt>
        <ExclusionAmt>69969</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>0</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>4359071</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>4346481</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>12590</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>12590</TotalRevenueColumnAmt>
        <ExclusionAmt>12590</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>56319</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>791110</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>377564</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>-321245</TotalRevenueColumnAmt>
        <ExclusionAmt>-321245</ExclusionAmt>
      </NetIncmFromFundraisingEvtGrp>
      <GamingGrossIncomeAmt>0</GamingGrossIncomeAmt>
      <GamingDirectExpensesAmt>0</GamingDirectExpensesAmt>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeFromGamingGrp>
      <GrossSalesOfInventoryAmt>13110</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>15005</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>-1895</TotalRevenueColumnAmt>
        <ExclusionAmt>-1895</ExclusionAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1855</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1164</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>691</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>1855</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>8743466</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2994309</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>-239890</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>208811</TotalAmt>
        <ProgramServicesAmt>208811</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>0</TotalAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>1468020</TotalAmt>
        <ProgramServicesAmt>832607</ProgramServicesAmt>
        <ManagementAndGeneralAmt>239471</ManagementAndGeneralAmt>
        <FundraisingAmt>395942</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>1317471</TotalAmt>
        <ProgramServicesAmt>664412</ProgramServicesAmt>
        <ManagementAndGeneralAmt>291738</ManagementAndGeneralAmt>
        <FundraisingAmt>361321</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>32933</TotalAmt>
        <ProgramServicesAmt>15992</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6138</ManagementAndGeneralAmt>
        <FundraisingAmt>10803</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>141846</TotalAmt>
        <ProgramServicesAmt>64801</ProgramServicesAmt>
        <ManagementAndGeneralAmt>42664</ManagementAndGeneralAmt>
        <FundraisingAmt>34381</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>189048</TotalAmt>
        <ProgramServicesAmt>103292</ProgramServicesAmt>
        <ManagementAndGeneralAmt>35201</ManagementAndGeneralAmt>
        <FundraisingAmt>50555</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>38327</TotalAmt>
        <ManagementAndGeneralAmt>38327</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>20683</TotalAmt>
        <ManagementAndGeneralAmt>20683</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>21008</TotalAmt>
        <ProgramServicesAmt>21008</ProgramServicesAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>3024920</TotalAmt>
        <ProgramServicesAmt>2761928</ProgramServicesAmt>
        <ManagementAndGeneralAmt>139161</ManagementAndGeneralAmt>
        <FundraisingAmt>123831</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>8059</TotalAmt>
        <ProgramServicesAmt>9665</ProgramServicesAmt>
        <FundraisingAmt>-1606</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>104603</TotalAmt>
        <ProgramServicesAmt>44392</ProgramServicesAmt>
        <ManagementAndGeneralAmt>31440</ManagementAndGeneralAmt>
        <FundraisingAmt>28771</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>18485</TotalAmt>
        <ProgramServicesAmt>10130</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2674</ManagementAndGeneralAmt>
        <FundraisingAmt>5681</FundraisingAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>242049</TotalAmt>
        <ProgramServicesAmt>134062</ProgramServicesAmt>
        <ManagementAndGeneralAmt>42495</ManagementAndGeneralAmt>
        <FundraisingAmt>65492</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>407716</TotalAmt>
        <ProgramServicesAmt>333159</ProgramServicesAmt>
        <ManagementAndGeneralAmt>35165</ManagementAndGeneralAmt>
        <FundraisingAmt>39392</FundraisingAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>13484</TotalAmt>
        <ProgramServicesAmt>9053</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2391</ManagementAndGeneralAmt>
        <FundraisingAmt>2040</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>1572</TotalAmt>
        <ManagementAndGeneralAmt>1572</ManagementAndGeneralAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>53891</TotalAmt>
        <ProgramServicesAmt>32639</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11732</ManagementAndGeneralAmt>
        <FundraisingAmt>9520</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>40639</TotalAmt>
        <ProgramServicesAmt>23020</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6301</ManagementAndGeneralAmt>
        <FundraisingAmt>11318</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>EVENT EXPENSES</Desc>
        <TotalAmt>633319</TotalAmt>
        <ProgramServicesAmt>602160</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6954</ManagementAndGeneralAmt>
        <FundraisingAmt>24205</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DUES AND SUBSCRIPTIONS</Desc>
        <TotalAmt>54427</TotalAmt>
        <ProgramServicesAmt>41680</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8579</ManagementAndGeneralAmt>
        <FundraisingAmt>4168</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SOFTWARE SUBSCRIPTIONS</Desc>
        <TotalAmt>119730</TotalAmt>
        <ProgramServicesAmt>86891</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7286</ManagementAndGeneralAmt>
        <FundraisingAmt>25553</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PRINTING/SHIPPING</Desc>
        <TotalAmt>164738</TotalAmt>
        <ProgramServicesAmt>115784</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3600</ManagementAndGeneralAmt>
        <FundraisingAmt>45354</FundraisingAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>18436</TotalAmt>
        <ProgramServicesAmt>5733</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3551</ManagementAndGeneralAmt>
        <FundraisingAmt>9152</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>8344215</TotalAmt>
        <ProgramServicesAmt>6121219</ProgramServicesAmt>
        <ManagementAndGeneralAmt>977123</ManagementAndGeneralAmt>
        <FundraisingAmt>1245873</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>427537</BOYAmt>
        <EOYAmt>631972</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>3412811</BOYAmt>
        <EOYAmt>4666634</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>2545654</BOYAmt>
        <EOYAmt>63801</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>96383</BOYAmt>
        <EOYAmt>163320</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>201183</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>123697</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>42331</BOYAmt>
        <EOYAmt>77486</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>3587758</BOYAmt>
        <EOYAmt>2793944</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>68638</BOYAmt>
        <EOYAmt>50107</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>433007</BOYAmt>
        <EOYAmt>437250</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>10614119</BOYAmt>
        <EOYAmt>8884514</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>979634</BOYAmt>
        <EOYAmt>1485931</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>117506</BOYAmt>
        <EOYAmt>66811</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>3802414</BOYAmt>
        <EOYAmt>1203745</EOYAmt>
      </DeferredRevenueGrp>
      <TaxExemptBondLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TaxExemptBondLiabilitiesGrp>
      <EscrowAccountLiabilityGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </EscrowAccountLiabilityGrp>
      <LoansFromOfficersDirectorsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <UnsecuredNotesLoansPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </UnsecuredNotesLoansPayableGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>21387</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>4899554</BOYAmt>
        <EOYAmt>2777874</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>2574767</BOYAmt>
        <EOYAmt>3287709</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>3139798</BOYAmt>
        <EOYAmt>2818931</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <PermanentlyRstrNetAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </PermanentlyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>5714565</BOYAmt>
        <EOYAmt>6106640</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>10614119</BOYAmt>
        <EOYAmt>8884514</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>399251</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-7176</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>5343299</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1278122</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5558537</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>5775504</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5989047</CurrentTaxYearAmt>
        <TotalAmt>23944509</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>5343299</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1278122</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5558537</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>5775504</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5989047</CurrentTaxYearAmt>
        <TotalAmt>23944509</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>10087274</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>13857235</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>11028</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>6852</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>14534</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>11635</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>69969</CurrentTaxYearAmt>
        <TotalAmt>114018</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <CurrentTaxYearMinus4YearsAmt>13250</CurrentTaxYearMinus4YearsAmt>
        <TotalAmt>13250</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>5860</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>401</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2101</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1060</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>691</CurrentTaxYearAmt>
        <TotalAmt>10113</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>24081890</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>6992146</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.57542</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.58163</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>PART II, SECTION A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION CHANGED THEIR ACCOUNTING YEAR END FROM DECEMBER 31 (CALENDAR YEAR) TO JUNE 30 (FISCAL YEAR) IN 2015. IN ACCORDANCE WITH THE INSTRUCTIONS, THE COLUMNS FOR YEARS 2013-2017 CORRESPOND TO THE 5 PRIOR TAX RETURNS FILED: 2013 = 2014 RETURN (12/31/2014 YEAR-END) 2014 = 2014 SHORT-YEAR RETURN (6/30/2015 YEAR-END) 2015 = 2015 RETURN (6/30/2016 YEAR-END) 2016 = 2016 RETURN (6/30/2017 YEAR-END) 2017 = 2017 RETURN (6/30/2018 YEAR-END)</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" />
    <IRS990ScheduleC documentId="IRS990ScheduleC">
      <TotalGrassrootsLobbyingGrp />
      <TotalDirectLobbyingGrp>
        <FilingOrganizationsTotalAmt>21008</FilingOrganizationsTotalAmt>
      </TotalDirectLobbyingGrp>
      <TotalLobbyingExpendGrp>
        <FilingOrganizationsTotalAmt>21008</FilingOrganizationsTotalAmt>
      </TotalLobbyingExpendGrp>
      <OtherExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>6100211</FilingOrganizationsTotalAmt>
      </OtherExemptPurposeExpendGrp>
      <TotalExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>6121219</FilingOrganizationsTotalAmt>
      </TotalExemptPurposeExpendGrp>
      <LobbyingNontaxableAmountGrp>
        <FilingOrganizationsTotalAmt>456061</FilingOrganizationsTotalAmt>
      </LobbyingNontaxableAmountGrp>
      <GrassrootsNontaxableGrp>
        <FilingOrganizationsTotalAmt>114015</FilingOrganizationsTotalAmt>
      </GrassrootsNontaxableGrp>
      <TotLbbyngGrassrootMnsNonTxGrp />
      <TotLbbyExpendMnsLbbyngNonTxGrp />
      <AvgLobbyingNontaxableAmountGrp>
        <CurrentYearMinus3Amt>0</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>0</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>507873</CurrentYearMinus1Amt>
        <CurrentYearAmt>456061</CurrentYearAmt>
        <TotalAmt>963934</TotalAmt>
      </AvgLobbyingNontaxableAmountGrp>
      <LobbyingCeilingAmt>1445901</LobbyingCeilingAmt>
      <AvgTotalLobbyingExpendGrp>
        <CurrentYearMinus3Amt>0</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>0</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>43156</CurrentYearMinus1Amt>
        <CurrentYearAmt>21008</CurrentYearAmt>
        <TotalAmt>64164</TotalAmt>
      </AvgTotalLobbyingExpendGrp>
      <AvgGrassrootsNontaxableGrp>
        <CurrentYearMinus3Amt>0</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>0</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>126968</CurrentYearMinus1Amt>
        <CurrentYearAmt>114015</CurrentYearAmt>
        <TotalAmt>240983</TotalAmt>
      </AvgGrassrootsNontaxableGrp>
      <GrassrootsCeilingAmt>361475</GrassrootsCeilingAmt>
      <AvgGrassrootsLobbyingExpendGrp>
        <CurrentYearMinus1Amt>120</CurrentYearMinus1Amt>
        <TotalAmt>120</TotalAmt>
      </AvgGrassrootsLobbyingExpendGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART II-A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION CHANGED THEIR ACCOUNTING YEAR END FROM DECEMBER 31 (CALENDAR YEAR) TO JUNE 30 (FISCAL YEAR) IN 2015. IN ACCORDANCE WITH THE INSTRUCTIONS, THE COLUMNS FOR YEARS 2014-2017 CORRESPOND TO THE 4 PRIOR TAX RETURNS FILED: 2014 = 2014 SHORT-YEAR RETURN (6/30/2015 YEAR-END) 2015 = 2015 RETURN (6/30/2016 YEAR-END) 2016 = 2016 RETURN (6/30/2017 YEAR-END) 2017 = 2017 RETURN (6/30/2018 YEAR-END)</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="IRS990ScheduleD">
      <ArtPublicExhibitionAmountsGrp />
      <HeldWorksArtGrp />
      <CYMinus3YrEndwmtFundGrp />
      <CYMinus4YrEndwmtFundGrp />
      <LandGrp />
      <BuildingsGrp />
      <LeaseholdImprovementsGrp />
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>145310</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>123697</DepreciationAmt>
        <BookValueAmt>21613</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>55873</OtherCostOrOtherBasisAmt>
        <BookValueAmt>55873</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>77486</TotalBookValueLandBuildingsAmt>
      <FederalIncomeTaxLiabilityAmt>0</FederalIncomeTaxLiabilityAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>CAPITAL LEASE OBGLIGATION</Desc>
        <Amt>21387</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>21387</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>9128859</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-7176</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>-7176</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>9136035</RevenueSubtotalAmt>
      <OtherRevenuesNotIncludedAmt>-392569</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>-392569</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>8743466</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>8736784</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>392569</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>392569</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>8344215</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>8344215</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>The Organization is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code, except for net income derived from unrelated business activities. In addition, the Organization qualifies for the charitable contribution deduction under Section 170(b)(1)(A) and has been classified as an organization other than a private foundation under IRC Section 509(a). The Organizations income tax filings are subject to audit by various taxing authorities. In evaluating the Organizations activities, management believes its position of tax-exempt status is based on current facts and circumstances and there have been no uncertain positions taken related to recording income taxes. The Organization maintains an employee commuter benefits plan, benefits under which are deemed to be unrelated business income as of January, 1, 2018. Due to the minimal amount, this unrelated business income tax is not reflected in these financial statements, but will be accounted for on the Organizations Form 990-T. There was no other unrelated business income during the prior fiscal year. It is the policy of the Organization to include in management and general expenses penalties and interest assessed by income taxing authorities. There are no penalties or interest from taxing authorities included in management and general expenses for the years ended June 30, 2018 and 2017.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 4B - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>Special Events ($377,564) Sale of Goods ($15,005) Total ($392,569)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>Special Events $377,564 Sale of Goods $15,005 Total $392,569</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="IRS990ScheduleG">
      <FundraisingEventInformationGrp>
        <Event1Nm>Broadway Belts</Event1Nm>
        <GrossReceiptsEvent1Amt>353552</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>297233</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>56319</GrossRevenueEvent1Amt>
        <RentFacilityCostsEvent1Amt>13015</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>60107</FoodAndBeverageEvent1Amt>
        <OtherDirectExpensesEvent1Amt>141588</OtherDirectExpensesEvent1Amt>
        <Event2Nm>PFF Walks</Event2Nm>
        <GrossReceiptsEvent2Amt>493877</GrossReceiptsEvent2Amt>
        <CharitableContriEvent2Amt>493877</CharitableContriEvent2Amt>
        <FoodAndBeverageEvent2Amt>971</FoodAndBeverageEvent2Amt>
        <OtherDirectExpensesEvent2Amt>161886</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>0</OtherEventsTotalCnt>
        <GrossReceiptsTotalAmt>847429</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>791110</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>56319</GrossRevenueTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>13015</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>61078</FoodAndBeverageTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>303474</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>377567</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>-321248</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="IRS990ScheduleI">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Brigham &amp; Women's Hospital</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>Samuel Ash MD 75 Francis Street</AddressLine1Txt>
          <CityNm>Boston</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042312909</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Chicago</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5235 S Harper Court 4th Floor</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60615</ZIPCd>
        </USAddress>
        <RecipientEIN>362177139</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Pennsylvania</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3451 Walnut Street Franklin Buildin</AddressLine1Txt>
          <AddressLine2Txt>Mailstop 6205</AddressLine2Txt>
          <CityNm>Philadelphia</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>191046205</ZIPCd>
        </USAddress>
        <RecipientEIN>231352685</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Stony Brook University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>460 Administration Building</AddressLine1Txt>
          <CityNm>Stony Brook</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>117941151</ZIPCd>
        </USAddress>
        <RecipientEIN>146013200</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
        <PurposeOfGrantTxt>Site Payment</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>4</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>For larger grants, the Organization requests semi-annual reports detailing the use of grant funds from the recipient organizations.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part II, Line 1(h) Purpose of Grant</FormAndLineReferenceDesc>
        <ExplanationTxt>Over the past year, using an automated image processing tool that we have developed, we analyzed over 10,000 computed tomography or CT scans of the chest done on people at the time they enrolled in the COPDGene study. We recently finished analyzing CT scans done 5 years later on 5,000 of those same people. Using this tool, we measured the amount of emphysema that these people have as a well as the amount of what are called "interstitial changes." In some people these interstitial changes are probably early pulmonary fibrosis. We have been particularly interested in what this early disease means for different people. Based on work done as part of this project, this year we found that not only is this early disease important, but it is particularly important in those people with emphysema, in whom it seems to enhance the negative effects of emphysema itself. We have completed analyzing the follow up CT scans using the automated analysis tool and will start measuring the progression of disease. This will help us to determine what factors predict the development and progression of early pulmonary fibrosis.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part II, Line 2(h) Purpose of Grant</FormAndLineReferenceDesc>
        <ExplanationTxt>Idiopathic Pulmonary Fibrosis (IPF) causes progressive scarring of the lungs, severe breathlessness, and hypoxemia. The cause of IPF is unknown, and despite current FDA-approved antifibrotic therapies overall survival remains 3-5 years after diagnosis. Gremlin-1, an inhibitor of bone morphogenic protein (BMP) signaling, has been implicated in pulmonary fibrosis, however the exact contribution is unclear. We have found significant upregulation of Gremlin1 expression in IPF lungs and bleomycin-treated mouse lungs. Furthermore, Gremlin1 expression is principally within lung fibroblasts in response to bleomycin. These findings suggest that fibroblast-derived Gremlin1 is critical for the development of pulmonary fibrosis. We will determine whether deletion of Gremlin1 within fibroblasts alters fibrogenesis, and whether Gremlin1 enhances fibroblast differentiation into activated myofibroblasts. The goal of this proposal is to define the mechanism by which Gremlin1 contributes to pulmonary fibrosis, and determine the potential for novel therapeutics involving Gremlin1.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part II, Line 3(H) Purpose of Grant</FormAndLineReferenceDesc>
        <ExplanationTxt>Despite the recent approval of perfenidone and Nintedanib to slow the progression of idiopathic pulmonary fibrosis (IPF), there is no way to reverse the established scarring (fibrosis). A key factor in IPF is production of excess scar tissue by a cell type known as fibroblasts (which normally function in wound healing). We propose to use a new technology that we developed for the treatment of cancer where we can genetically redirect blood cells (lymphocytes) to attack "scar-producing" activated fibroblasts in the fibrotic lung. We will test this approach in 3 mouse models of lung fibrosis. If successful and safe, this study will pave the way towards clinical trials that could change the treatment paradigm for IPF and potentially reverse lung scarring and improve lung function.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ">
      <HousingAllowanceOrResidenceInd>X</HousingAllowanceOrResidenceInd>
      <WrittenPolicyRefTAndEExpnssInd>false</WrittenPolicyRefTAndEExpnssInd>
      <SubstantiationRequiredInd>false</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>true</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Scott Staszak</PersonNm>
        <TitleTxt>Chief Operating Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>219462</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>47000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>7994</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>274456</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Laura Sadler</PersonNm>
        <TitleTxt>Chief Program &amp; Bus Dev Offcr</TitleTxt>
        <BaseCompensationFilingOrgAmt>170461</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>500</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5384</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>8096</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>184441</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 1a</FormAndLineReferenceDesc>
        <ExplanationTxt>CEO resides in MD and cannot relocate at this time, however, he needs to spend substantial time in Chicago and therefore PFF agreed to provide a housing allowance.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 1b</FormAndLineReferenceDesc>
        <ExplanationTxt>Details are disclosed in CEO's employment contract. We do not offer this arrangement to other staff members and thus do not have a written policy for a housing allowance.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleM documentId="IRS990ScheduleM">
      <WorksOfArtGrp />
      <ArtHistoricalTreasuresGrp />
      <ArtFractionalInterestGrp />
      <BooksAndPublicationsGrp />
      <ClothingAndHouseholdGoodsGrp />
      <CarsAndOtherVehiclesGrp />
      <BoatsAndPlanesGrp />
      <IntellectualPropertyGrp />
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>9</ContributionCnt>
        <NoncashContributionsRptF990Amt>100072</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FMV</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <SecuritiesCloselyHeldStockGrp />
      <SecurPrtnrshpTrustIntrstsGrp />
      <SecuritiesMiscellaneousGrp />
      <QualifiedContribHistStructGrp />
      <QualifiedContribOtherGrp />
      <RealEstateResidentialGrp />
      <RealEstateCommercialGrp />
      <RealEstateOtherGrp />
      <CollectiblesGrp />
      <FoodInventoryGrp />
      <DrugsAndMedicalSuppliesGrp />
      <TaxidermyGrp />
      <HistoricalArtifactsGrp />
      <ScientificSpecimensGrp />
      <ArchaeologicalArtifactsGrp />
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>Other</Desc>
        <ContributionCnt>3</ContributionCnt>
        <NoncashContributionsRptF990Amt>12041</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>fmv</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>true</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>false</ThirdPartiesUsedInd>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="IRS990ScheduleO">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINES 4A-4C</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTINUED FROM FORM 990, PART III, LINE 4A: The Registry is an electronic database of patient information that will be de-identified (made anonymous) and independently managed by a data-coordinating center. The Registry also collects biological specimens that patients have agreed to give, which are de-identified and independently managed by a medical specimen storage facility associated with the data-coordinating center. The goals of the PFF Patient Registry are to facilitate the development of effective therapies by providing researchers with data to address specific research questions and facilitate recruitment for clinical trials. To meet these goals, the Registry will collect accurate clinical data on the current care, treatment, and quality of life for patients with diverse forms of pulmonary fibrosis as well as biological specimens when possible. This vital program is close to fully funded for the initial 5 year plan, but additional funding is needed to complete the initial plan and then to allow the PFF Patient Registry to expand beyond the original plan for 2,000 patients, providing more clinical data and expediting research. As of June 30, 2018, the PFF Patient Registry has activated 45 sites and identified 2,001 patients for enrollment. To learn more about the PFF Patient Registry, please go to: http://bit.ly/pffregistry. CONTINUED FROM FORM 990, PART III, LINE 4B: The goal of the PFF Summit is to foster a collaborative environment to improve education and awareness of PF and to identify new approaches to treat, and ultimately cure, this devastating disease. The PFF summit features an innovative continuing medical education (CME) program for Health Care Professionals and sessions for PF patients and caregivers that address their growing educational needs. (Note: Some expenses for the PFF Summit 2017 were included in the 2016 Form 990). CONTINUED FROM FORM 990, PART III, LINE 4C: The Foundations printed educational materials created in 2017-2018 for patients, caregivers, and physicians include: Supplemental Oxygen Quick-Start Guide (available in English, Spanish, Simplified Chinese, and Russian), Traveling with Supplemental Oxygen Brochure, PF Fact Sheet, and About PFF Brochure. These printed educational materials are distributed through the PFF Patient Communication Center and at education events and conferences. Website updates include educational information under the Life with PF/Education and Support tab. In order to give patients easier access to locate clinical trials, the PFF added a clinical trials finder application to the website, which can be found at http://bit.ly/pfftrialfinder. The PFF also began its "Life with PF" video series which includes videos on a variety of topics, including disease education, stories from real people living with pulmonary fibrosis and idiopathic pulmonary fibrosis, support group training, and information and services provided by the PFF. These videos can be found at http://bit.ly/lifewithpf and on the Foundations YouTube channel. The PFF Disease Education Webinar Series engages the PF community in an online webinar discussion where they learn from, connect with, and pose questions to leading pulmonary fibrosis specialists each month. Eight webinars were presented in fiscal year 2017-18 and all can be viewed on the PFF website at https://bit.ly/pffwebinars and on the Foundations YouTube channel.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4D</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER PROGRAM SERVICES: 1. PFF Care Center Network: The goal of the PFF Care Center Network is to elevate the standard of care for patients with pulmonary fibrosis by connecting leading medical centers throughout the U.S. that have expertise in treating fibrotic lung diseases. The institutions that comprise the network use a multidisciplinary approach to deliver comprehensive patient care with specialized care teams which include individuals with expertise in pulmonary medicine, rheumatology, radiology, pathology, gastroenterology, and thoracic surgery. This multipronged, collaborative approach is critical to managing a complex disease like pulmonary fibrosis and ensuring individuals receive an accurate diagnosis, obtain quality clinical care, and acquire important support services. Health care experts at CCN sites have extensive experience in the treatment of PF and are dedicated to the care of patients with this disease. The specific cause of PF, whether environmental, related to another illness, unknown (idiopathic), or otherwise, can significantly impact the progression of the disease and treatment options, so it is important that each patient be considered and treated individually. Because of the CCN sites multidisciplinary approach, patients benefit from a more accurate diagnosis, as well as recommendations for continuing care, assistance in delivering essential social services and the opportunity to participate in collaborative research. In March of 2018, the PFF called for new site applications and added 15 additional sites, bringing the total across the United States to 60 centers. This increased the CCNs MSA (Metropolitan Statistical Area) coverage to 80%, bringing it closer to its goal of 90% of the total U.S. population having access to PFF CCN site within a 2-hour or 120-mile radius. Our VP of Research and Development is a new position added this year, which has allowed us to visit to over half of the 60 CCN sites to learn more about their best practices, as well as share the resources available to them at the PFF. To learn more about the PFF Care Center Network or find a PFF Care Center please go to: https://bit.ly/pffwebinars 2. Outreach and Awareness: The PFF Ambassador program empowers patients, caregivers, and health care professionals as spokespersons for the PF community on behalf of the PFF. PFF Ambassadors promote disease awareness, provide up-to-date information, and offer hope and inspiration to those affected by pulmonary fibrosis. PFF Ambassadors are available to speak at PFF Care Center Network events, support group meetings, fundraising events, and other disease awareness and education programs. During the fiscal year, the PFF accepted 16 new PFF Ambassadors into the program. These Ambassadors consist of pulmonary fibrosis patients, caregivers and lung transplant recipients. PFF Ambassadors spoke at 39 events including Support Group meetings, educational conferences and fundraisers. The PFF Daughters program was founded to expand awareness of pulmonary fibrosis, especially among policymakers, via grassroots events and fundraisers across the nation, in order to generate a broader understanding of the impact the disease has on those living with PF and their families. Members of PFF Daughters join together to use their collective voice to increase awareness about PF, advocate for improved care for people with PF, and raise support for continued research efforts. Membership in the PFF Daughters program is open to anyone affected by pulmonary fibrosis - past, present and future. By engaging members of the community through a new outreach tool and adding the more inclusive name of "PFF Advocates," the PFF was able to expand participation to over 500 people. In September, members joined other advocates in Washington, DC to raise awareness about the importance of medical research. In November, members participated in training during the PFF Summit. Members also participated in teleconferences to provide them with relevant updates about research, policy, community events, and the program. The PFF created a video about a member of the PFF Daughters to raise awareness about PF and help others understand the life of a PF patient. Global Pulmonary Fibrosis Awareness Month (September) is when the PF community unites as a collective voice to enhance disease awareness and provide outreach to those in need. During Global Pulmonary Fibrosis Awareness Month, the PF community joined the PFF and participated in the #BlueUp4PF campaign, attended educational events, hosted Team PFF fundraising events, participated in webinars and spread disease awareness through social media. 3. Research Grants: The Pulmonary Fibrosis Foundation (PFF) places enormous importance on creating an environment that will assist in the development of effective treatments for pulmonary fibrosis (PF). In addition to creating the PFF Patient Registry to provide researchers with data to address specific research questions, we are developing advocacy efforts, encouraging collaborative relations between industry and academic researchers, delivering key communications to patients, and developing solutions to bridge existing gaps in PF research. The PFF Research Fund supports projects that offer a high likelihood of improving the understanding of PF in the following areas: basic science, translational science, clinical medicine/research and social science/quality of life. The Scientific Advisory Committee administers the peer-reviewed process which funds four $50,000 grants per grant cycle. PFF also sponsors other smaller grants that fit the research guidelines. 4. PFF Patient Communication Center (PCC): The PFF Patient Communication Center (PCC) serves as the central information hub for pulmonary fibrosis patients, caregivers, the Support Group Leader Network (see Support Group section), and health care professionals. The PCC staff answers questions about the availability of support services and other essential resources, and provides information that is tailored and provides information that is tailored to individuals needs. Resources available include: information on PFF programs, educational and advocacy materials, how to find medical care, access to support services, information about available treatments, and how to find clinical trials. The Foundation continuously surveys the PF community to determine additional educational materials or translations of current materials that are needed and works to create and provide those materials. The Foundation also facilitates physician education by providing materials at educational conferences. 5. Support Groups: The PFF Support Group Leader Network provides a forum for PF support group leaders to connect, exchange ideas, and share best practices. The PFFs Support Group Network consists of over 100 support groups across the country. Support Group leaders have the opportunity to meet in person at least once a year for training and the exchange of ideas, and meet periodically throughout the year via teleconference. Online Support Group Communities are a great way for patients, caregivers, family members, and friends to virtually connect for support and information. For those who are unable to attend an in-person group, or simply want additional interactions between meetings, the Pulmonary Fibrosis Foundation offers two online support communities: PatientsLikeMe and Rareconnect, as well as our new telephone-based support group: PFF Voices. PFF Voices meets once per month over the phone in a conference call setting. Each monthly meeting provides a chance to discuss different topics related to pulmonary fibrosis, share personal stories, ask questions and provide support to one another. Visit http://bit.ly/pffsupport to learn more. 6. Advocacy: During the year, the PFF engaged policymakers in advocating for increased funding for pulmonary fibrosis research and improved access to oxygen for patients. The PFF was a founding member of a coalition of patient and healthcare provider organizations that was created to address patient concerns about access to oxygen. The coalition has been active in meeting with members of Congress and agency representatives to discuss possible improvements to access to oxygen. The PFF worked on drafting a PF-related question for the annual National Institutes of Health hearing held by the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. The PFF also worked with congressional champions on drafting congressional report language related to pulmonary fibrosis.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXISTS, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINES 15A &amp; B:</FormAndLineReferenceDesc>
        <ExplanationTxt>Chief Executive Officer and Chief Operating Officer's compensation was approved by the Executive Committee, which serves as the compensation committee. This approval was based on a review by an independent compensation consultant and is supported by a written employment contract. The committee also reviewed compensation surveys and Form 990s of other organizations to ensure the compensation was appropriate. The salary for the Chief Programs and Business Development Officer was not reviewed by the Compensation Committee, but the salary was in line with the market.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:SITE PAYMENTS TOTAL FEES:1333876</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:MEDICAL CONSULTANT TOTAL FEES:470594</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:OTHER CONSULTANT TOTAL FEES:409447</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:REGISTRY DCC CONSULTANT TOTAL FEES:230070</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:COLLECTION KIT TOTAL FEES:130125</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:RECRUITMENT TOTAL FEES:110610</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:76531</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:45928</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:CME TOTAL FEES:45875</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:MARKETING CONSULTANT TOTAL FEES:35313</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:MEDIA RELATIONS TOTAL FEES:24212</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:DP CARD PROCESSING FEES TOTAL FEES:21072</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:GRAPHIC DESIGN TOTAL FEES:18058</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:IT CONSULTANT TOTAL FEES:15467</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:EMPLOYEE ADMINISTRATION TOTAL FEES:13419</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:STIPENDS TOTAL FEES:13250</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:INVESTMENT FEES TOTAL FEES:11409</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:WRITING/EDITING TOTAL FEES:9565</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:PHOTOGRAPHY TOTAL FEES:7875</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:TRANSLATION TOTAL FEES:2324</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART IX LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION:FIRST GIVING PROCESSING FEE TOTAL FEES:-100</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>